INSR and neoplasm: AG1024 is a reversible, competitive inhibitor of insulin receptor (IR) and insulin-like growth factor 1 receptor (IGF-1R) [13] that induces apoptosis, imparts anti-cancer activity, and significantly delays tumor growth [14].